Intervention

Botulinum Toxin Type A

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7

Recruiting0

Common conditions14

Lead sponsors shown7

Clinical trials

7 shown

Kinematic-based BoNT-A Bilateral Upper Limb PD TherapyNCT02668497 · 2016-03-01

UNKNOWN

Intragastric Injections of Botox for the Treatment of ObesityNCT02035397 · 2014-02-01

UNKNOWN

Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MSNCT01911377 · 2013-10-01

TERMINATED

Botulinum Toxin A (Botox) in Tissue Expander Breast ReconstructionNCT01591746 · 2012-08-01

COMPLETED

The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) TremorNCT01018485 · 2008-10-01

COMPLETED

Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's DiseaseNCT00477802 · 2007-05-01

TERMINATED

A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot PainNCT00336349 · 2006-06-01

COMPLETED

Common conditions

Neuropathic Pain2 Allodynia1 BRCA1 Mutation1 BRCA2 Mutation1 Breast Cancer1 Breast Diseases1 Diabetes Mellitus1 Multiple Sclerosis1 Neoplasms1 Obesity, Morbid1 Pain, Postoperative1 Parkinson Disease1 Parkinson's Disease1 Tremor1

Leading sponsors

Mayo Clinic1 Melbourne Health1 Norwegian University of Science and Technology1 Taipei Medical University Hospital1 University of Cincinnati1 University of Manitoba1 Western University, Canada1

Trial status mix

COMPLETED3

TERMINATED2

UNKNOWN2

Phase mix

PHASE23

PHASE32

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.